Production & Manufacturing
BioPharma
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development and manufacturing organization (CDMO) is pivotal to a successful pharmaceutical development journey. This decision hinges on...
News
Biovian announces over €50 million investment in manufacturing facility...
Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major investment of over €50 million to expand its manufacturing...
News
New PAT – Based Strategy Stops Membrane Fouling In...
A recent article published in the Journal of Membrane Science presents a new approach for implementing a robust single-pass tangential flow filtration (SP-TFF) operation in...
BioPharma
Cell And Gene Therapy CDMO Services Market Is On...
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which was valued at USD 5,193.7 million in 2022, is expected...
BioPharma
Lack of Experience Hinders CDMOs In Cell And Gene...
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy...
Drug Research
WHO & Republic of Korea Tie-Up For Biomanufacturing Training
The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a worldwide...
BioPharma
Cell and Gene Therapy CDMO Targets North American Growth...
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.